Medetomidine preparations for transdermal administration

Details Medetomidine preparations for transdermal administration Medetomidine preparations for transdermal administration

1993-11-12

1995-08-01

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

424447, 424448, 424449, A61L 1544, A61K 970, A61F 1300, A61F 1302

Patent

active

054380677

ABSTRACT:
Salts of medetomidine and optically active enantiomers, thereof, particularly the d-enantiomer are disclosed. These salts may be used to regulate the rate of the transdermal administration of active drugs. The transdermal delivery system comprises a drug impermeable backing layer and an adhesive layer wherein the medetomidine is dispersed throughout the adhesive layer.

REFERENCES:
patent: 4783477 (1988-11-01), Lammintausta et al.
patent: 5124157 (1992-06-01), Colley et al.
patent: 5217718 (1993-06-01), Colley et al.

Affiliated with

Also associated with

Rating

Medetomidine preparations for transdermal administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medetomidine preparations for transdermal administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medetomidine preparations for transdermal administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-733992